NasdaqGS - Delayed Quote USD
Y-mAbs Therapeutics, Inc. (YMAB)
4.2600
-0.5600
(-11.62%)
At close: April 22 at 4:00:01 PM EDT
4.1900
-0.07
(-1.64%)
After hours: April 22 at 6:07:16 PM EDT
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 212,100 | 5 |
Sales | 14,727 | 2 |
Net Shares Purchased (Sold) | 197,373 | 7 |
Total Insider Shares Held | 5.57M | -- |
% Net Shares Purchased (Sold) | 3.70% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
GAD THOMAS Officer and Director | Sale at price 5.23 per share. | Direct | 56,536 | Mar 7, 2025 |
ROSSI MICHAEL J Chief Executive Officer | Sale at price 5.20 per share. | Direct | 20,368 | Mar 7, 2025 |
PFREUNDSCHUH PETER P Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 17, 2025 |
LAROCCA JOHN General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 17, 2025 |
WILMS JORIS Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 17, 2025 |
GAD THOMAS Officer and Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 17, 2025 |
ROSSI MICHAEL J Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 17, 2025 |
GAD THOMAS Officer and Director | Conversion of Exercise of derivative security at price 4.38 per share. | Direct | 100,000 | Sep 19, 2024 |
GAD THOMAS Officer and Director | Sale at price 12.97 - 13.47 per share. | Indirect | 1,264,650 | Sep 16, 2024 |
LUND-HANSEN TORBEN Chief Technology Officer | Sale at price 15.37 per share. | Direct | 768,500 | Aug 28, 2024 |
LUND-HANSEN TORBEN Chief Technology Officer | Conversion of Exercise of derivative security at price 4.38 per share. | Direct | 219,000 | Aug 28, 2024 |
WILMS JORIS Chief Operating Officer | Sale at price 14.69 per share. | Direct | 73,450 | Aug 26, 2024 |
PFREUNDSCHUH PETER P Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 12, 2024 |
GAD THOMAS Officer and Director | Sale at price 12.00 - 12.03 per share. | Indirect | 841,050 | Jun 11, 2024 |
GILL DAVID N. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 11, 2024 |
HEALY JAMES I Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 11, 2024 |
TAGLIAFERRI MARY ANN Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 11, 2024 |
HAMILL LAURA Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 11, 2024 |
TYAGI ASHUTOSH Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 11, 2024 |
WEDELL-WEDELLSBORG JOHAN Director and Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 11, 2024 |
BER GERARD Director | Sale at price 12.00 per share. | Direct | 8,664 | Jun 10, 2024 |
KRUSE BO Chief Financial Officer | Sale at price 12.03 - 12.07 per share. | Direct | 723,055 | May 31, 2024 |
KRUSE BO Chief Financial Officer | Conversion of Exercise of derivative security at price 2.00 per share. | Direct | 120,000 | May 31, 2024 |
GAD THOMAS Officer and Director | Sale at price 12.00 - 13.00 per share. | Indirect | 395,563 | May 23, 2024 |
TAGLIAFERRI MARY ANN Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 12, 2024 |
GAD THOMAS Officer and Director | Sale at price 16.44 per share. | Direct | 64,116 | Mar 5, 2024 |
RAJAH VIGNESH Officer | Sale at price 16.53 per share. | Direct | 28,283 | Mar 5, 2024 |
SMITH SUSAN LAURA Officer | Sale at price 16.55 per share. | Direct | 27,837 | Mar 5, 2024 |
ROSSI MICHAEL J Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2024 |
WILMS JORIS Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 18, 2024 |
KRUSE BO Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 18, 2024 |
GAD THOMAS Officer and Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 18, 2024 |
LUND-HANSEN TORBEN Chief Technology Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 18, 2024 |
LISBY STEEN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 18, 2024 |
RAJAH VIGNESH Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 18, 2024 |
SMITH SUSAN LAURA Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 18, 2024 |
GAD THOMAS Officer and Director | Conversion of Exercise of derivative security at price 2.00 per share. | Direct | 100,000 | Dec 21, 2023 |
GAD THOMAS Officer and Director | Sale at price 6.58 - 6.83 per share. | Indirect | 1,001,000 | Dec 15, 2023 |
WEDELL-WEDELLSBORG JOHAN Director | Purchase at price 6.50 - 7.01 per share. | Indirect | 890,411 | Dec 11, 2023 |
WEDELL-WEDELLSBORG JOHAN Director | Purchase at price 6.85 per share. | Indirect | 44,232 | Dec 11, 2023 |
WG BIOTECH APS Director | Purchase at price 6.50 - 7.01 per share. | Direct | 890,411 | Dec 11, 2023 |
WG BIOTECH APS Director | Purchase at price 6.85 per share. | Direct | 44,232 | Dec 11, 2023 |
WEDELL-WEDELLSBORG JOHAN Director | Purchase at price 5.97 per share. | Indirect | 309,477 | Nov 29, 2023 |
WG BIOTECH APS Director | Purchase at price 5.97 per share. | Direct | 309,477 | Nov 29, 2023 |
WEDELL-WEDELLSBORG JOHAN Director | Purchase at price 5.49 - 5.81 per share. | Indirect | 521,294 | Nov 28, 2023 |
WG BIOTECH APS Unknown | Purchase at price 5.49 - 5.81 per share. | Direct | 521,294 | Nov 28, 2023 |
GAD THOMAS Officer and Director | Sale at price 5.30 - 5.31 per share. | Indirect | 795,382 | Nov 21, 2023 |
GILL DAVID N. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 8, 2023 |
HEALY JAMES I Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 8, 2023 |
BER GERARD Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 8, 2023 |
Related Tickers
STOK Stoke Therapeutics, Inc.
9.22
+7.08%
RVMD Revolution Medicines, Inc.
36.86
+0.82%
REPL Replimune Group, Inc.
8.71
-0.63%
OLMA Olema Pharmaceuticals, Inc.
4.9600
+4.42%
SGMT Sagimet Biosciences Inc.
2.5500
+6.69%
BCYC Bicycle Therapeutics plc
8.73
+16.24%
TNGX Tango Therapeutics, Inc.
1.4900
+7.97%
CGEM Cullinan Therapeutics, Inc.
8.37
+3.33%
SRRK Scholar Rock Holding Corporation
31.64
+6.14%
DAWN Day One Biopharmaceuticals, Inc.
7.33
+2.66%